Guerbet is a limited liability company incorporated under the laws of France with securities listed on Euronext Paris, France. Consequently, our corporate governance framework reflects the mandatory provisions of French corporate law, the securities laws and regulations applying to Guerbet as a corporation listed in France States. In addition, the Company’s corporate governance principles refer to the AFEP-MEDEF Code.
On May 21, 2010, Guerbet adopted the French form of a joint stock company governed by a Board of Directors (Société Anonyme à Conseil d'administration). This legal structure upholds a clear separation between management functions assumed by the Executive Committee and the functions of oversight assured by the Board of Directors, which represents the shareholders.
Board of Directors
Marie-Claire Janailhac-Fritsch
Chairwoman of the Board
Céline Lamort
Director
Claire Massiot-Jouault
Director
Didier Izabel
Director
Eric Guerbet
Director
Marion Barbier
Director
Mark Fouquet
Director
Nicolas Louvet
Director
Thibault Viort
Director
Isabelle Raynal
Employee Director
Executive Committee
David Hale
Chief Executive Officer & Chief Commercial Officer ad interim
Jean-François Blanc
Technical Operations VP
Claire Corot
Research, Innovation & Business Development VP
Jérôme Estampes
Chief Financial Officer
Philippe Bourrinet
Development, Medical & Regulatory Affairs VP
Pétra Zalabak
Human Resources VP
François Nicolas
Chief Digital Officer & Contrast Injection Systems R&D VP
Pierre André
Chief Pharmaceutical Officer, Deputy CEO
Valérie Brissart
SVP Diagnostic Imaging
Mathieu Elie
Chief Commercial Officer Asia Pacific